{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-014329","form_type":"8-K","ticker":null,"cik":"0001460602","company_name":"Orgenesis Inc.","filed_at":"2024-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.495670+00:00","generated_at":"2026-06-03T23:59:59.045142+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Orgenesis subsidiary sells five OMPULs to Germfree for $8.34M, enters 10-year collaboration","bullets":["Orgenesis Maryland sells five Octomera Mobile Processing Units & Labs (OMPULs) to Germfree for $8.34M.","Germfree gets a worldwide royalty-free license to Orgenesis' Quality Management Systems Framework (OQMSF).","Germfree will exclusively manufacture and distribute OMPULs for Orgenesis worldwide for 10 years.","Each party pays the other a 15% commission on Net Sales of OMPULs/services when customer is introduced.","Strategic Collaboration Committee with 3 members from each party to oversee joint marketing and sales pipeline."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-014329","json":"https://secwatch.observer/filing/0001493152-24-014329.json","markdown":"https://secwatch.observer/filing/0001493152-24-014329.md","text":"https://secwatch.observer/filing/0001493152-24-014329.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1460602/000149315224014329/0001493152-24-014329-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1460602/000149315224014329/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T23:59:59.045142+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"477db5a794ae73907c54c7156f6d39186c606509","claim":"Orgenesis Inc. entered into Asset Purchase and Strategic Collaboration Agreement with Griffin Fund 3 BIDCO, Inc., (\"Germfree\") valued at aggregate purchase price of $8,340,000 (effective 2024-04-05).","evidence_excerpt":"On April 5, 2024, Orgenesis Maryland LLC (“Orgenesis Maryland”), a wholly-owned subsidiary of Orgenesis Inc., entered into an Asset Purchase and Strategic Collaboration Agreement (the “Purchase Agreement”) with Griffin Fund 3 BIDCO, Inc., (“Germfree\"), for the sale by Orgenesis Maryland of five Octomera Mobile Processing Units and Labs (“OMPULs”) to Germfree","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1460602/000149315224014329/0001493152-24-014329-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Griffin Fund 3 BIDCO, Inc., (\"Germfree\")"},{"label":"Value","value":"aggregate purchase price of $8,340,000"},{"label":"Effective","value":"2024-04-05"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}